title: Re-challenging with anti-CD38 monotherapy in triple-refractory multiple myeloma patients is a feasible and safe approach.
authors.affiliation: Centre for Haematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.|Haematology Centre, Karolinska University Hospital Huddinge, Stockholm, Sweden.|Center for Diseases of Aging, Vaccine and Gene Therapy Institute of Florida, Port St. Lucie, FL, USA.
authors.forename: Evren
authors.initials: E
authors.lastname: Alici
authors.affiliation: Centre for Haematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.|Center for Diseases of Aging, Vaccine and Gene Therapy Institute of Florida, Port St. Lucie, FL, USA.
authors.forename: Michael
authors.initials: M
authors.lastname: Chrobok
authors.affiliation: Centre for Haematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.|Haematology Centre, Karolinska University Hospital Huddinge, Stockholm, Sweden.
authors.forename: Johan
authors.initials: J
authors.lastname: Lund
authors.affiliation: Janssen Research & Development LLC, Spring House, PA, USA.
authors.forename: Tahamtan
authors.initials: T
authors.lastname: Ahmadi
authors.affiliation: Janssen Research & Development LLC, Spring House, PA, USA.
authors.forename: Imran
authors.initials: I
authors.lastname: Khan
authors.affiliation: Centre for Haematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.|Center for Diseases of Aging, Vaccine and Gene Therapy Institute of Florida, Port St. Lucie, FL, USA.
authors.forename: Adil D
authors.initials: AD
authors.lastname: Duru
authors.affiliation: Centre for Haematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden. hareth.nahi@karolinska.se.|Haematology Centre, Karolinska University Hospital Huddinge, Stockholm, Sweden. hareth.nahi@karolinska.se.|Center for Diseases of Aging, Vaccine and Gene Therapy Institute of Florida, Port St. Lucie, FL, USA. hareth.nahi@karolinska.se.
authors.forename: Hareth
authors.initials: H
authors.lastname: Nahi
mesh_terms: D051997:ADP-ribosyl Cyclase 1 / Q000276:immunology*; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008562:Membrane Glycoproteins / Q000276:immunology*; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D016879:Salvage Therapy / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D008562:Membrane Glycoproteins; C556306:daratumumab; C498154:CD38 protein, human; D051997:ADP-ribosyl Cyclase 1
keywords: CD38; daratumumab; relapsed and refractory multiple myeloma; response